Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1287)

  • Pérez-Recio, S; Grijota-Camino, MD; Anibarro, L; Rabuñal-Rey, R; Sabria, J; Gijón-Vidaurreta, P; Pomar, V; García-Gasalla, M; Domínguez-Castellano, A; Trigo, M; Santos, MJ; Cebollero, A; Rodríguez, S; Moga, E; Penas-Truque, A; Martos, C; Ruiz-Serrano, MJ; Garcia-de-Cara, EI; Alcaide, F; Santin, M.

    Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

    PLoS One. 2023; 18(8): Nº de citas: 4 [doi:10.1371/journal.pone.0285917]

  • Caamano, E; Velasco, L; Garcia, MV; Asencio, JM; Pineiro, P; Hortal, J; Garutti, I.

    Prognostic factors for deterioration of quality of life one year after admission to ICU for severe SARS-COV2 infection

    QUALITY OF LIFE RESEARCH. 2023; 33(1): 123-132 Nº de citas: 7 [doi:10.1007/s11136-023-03503-0]

  • Giacobbe, DR; Dettori, S; Di Pilato, V; Asperges, E; Ball, L; Berti, E; Blennow, O; Bruzzone, B; Calvet, L; Marzani, FC; Casabella, A; Choudaly, S; Dartevel, A; De Pascale, G; Di Meco, G; Fallon, M; Galerneau, LM; Gallego, M; Giacomini, M; Sáez, AG; Hänsel, L; Icardi, G; Koehler, P; Lagrou, K; Lahmer, T; White, PL; Magnasco, L; Marchese, A; Marelli, C; Marín-Arriaza, M; Martin-Loeches, I; Mekontso-Dessap, A; Mikulska, M; Mularoni, A; Nordlander, A; Poissy, J; Russelli, G; Signori, A; Tascini, C; Vaconsin, LM; Vargas, J; Vena, A; Wauters, J; Pelosi, P; Timsit, JF; Bassetti, M.

    Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

    CRITICAL CARE. 2023; 27(1): [doi:10.1186/s13054-023-04608-1]

  • Becerra-Aparicio, F; Gomez-Zorrilla, S; Hernandez-Garcia, M; Gijon, D; Siverio, A; Berbel, D; Sanchez-Carrillo, C; Cercenado, E; Rivera, A; de Malet, A; Xercavins, M; de Gopegui, ER; Canoura-Fernandez, L; Martinez, JA; Seral, C; Del Pozo, JL; Cotarelo, M; Diaz-Reganon, J; Canton, R; Oliver, A; Horcajada, JP; Ruiz-Garbajosa, P.

    Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9): 2291-2296 Nº de citas: 12 [doi:10.1093/jac/dkad234]

  • Bouza, E; Navarro, JAG; Alonso, S; Alonso, JCD; Escobar, C; Gomez, BJF; Borras, MIG; Rojas, AJG; Pavon, FJG; Gracia, D; Rodriguez, JG; Kestler, M; Cuervo, FM; Sanchez, FJM; Melero, C; Villanueva, RM; Munoz, P; Palomo, E; Garrote, JMPC; Rexach, JAS; Santaeugenia, SJ; Santabalbina, FJT; Astiz, MTV.

    Infection control in long term care institutions for the elderly: A reflection document on the situation in Spain

    Revista Espanola de Quimioterapia. 2023; 36(4): 346-379 Nº de citas: 9 [doi:10.37201/req/002.2023]

  • Alonso-Menchen, D; Bouza, E; Valerio, M; de Alarcon, A; Gutierrez-Carretero, E; Miro, JM; Goenaga-Sanchez, MA; Plata-Ciezar, A; Gonzalez-Rico, C; Lopez-Cortes, LE; Esteban, MAR; Martinez-Marcos, FJ; Munoz, P.

    Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data From the GAMES Series (2008-2021)

    Open Forum Infectious Diseases. 2023; 10(8): Nº de citas: 9 [doi:10.1093/ofid/ofad393]

  • Larrosa MN; Canut-Blasco A; Benito N; Cantón R; Cercenado E; Docobo-Pérez F; Fernández-Cuenca F; Fernández-Domínguez J; Guinea J; López-Navas A; Moreno MÁ; Morosini MI; Navarro F; Martínez-Martínez L; Oliver A.

    Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2023; 41(7): 430-435 Nº de citas: 6 [doi:10.1016/j.eimce.2022.09.002]

  • Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.

    Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

    PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]

  • Penas-Utrilla, D; Perez-Lago, L; Molero-Salinas, A; Estevez, A; Sanz, A; Herranz, M; Martinez-Laperche, C; Andres-Zayas, C; Veintimilla, C; Catalan, P; Alonso, R; Munoz, P; de Viedma, DG.

    Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

    Genome Medicine. 2023; 15(1): Nº de citas: 4 [doi:10.1186/s13073-023-01198-z]

  • Penas-Utrilla, D; Sanz, A; Catalan, P; Veintimilla, C; Alcala, L; Alonso, R; Munoz, P; Perez-Lago, L; de Viedma, DG.

    A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC MICROBIOLOGY. 2023; 23(1): [doi:10.1186/s12866-023-02924-8]

  • Zaballos, M; Fernandez, I; Rodriguez, L; Orozco, S; Garcia, A; Juncos, M; Alvarez-Zaballos, S; Pineiro, P; Hortal, J.

    Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients

    Scientific Reports. 2023; 13(1): Nº de citas: 3 [doi:10.1038/s41598-023-37688-8]

  • Diaz-Garcia, J; Mesquida, A; Machado, M; Sanchez-Carrillo, C; Munoz, P; Escribano, P; Guinea, J.

    Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity

    MEDICAL MYCOLOGY. 2023; 61(7): Nº de citas: 8 [doi:10.1093/mmy/myad072]

  • Puerta-Alcalde, P; Monzo-Gallo, P; Aguilar-Guisado, M; Ramos, JC; Laporte-Amargos, J; Machado, M; Martin-Davila, P; Franch-Sarto, M; Sanchez-Romero, I; Badiola, J; Gomez, L; Ruiz-Camps, I; Yanez, L; Vazquez, L; Chumbita, M; Marco, F; Soriano, A; Gonzalez, P; Fernandez-Cruz, A; Batlle, M; Fortun, J; Guinea, J; Gudiol, C; Garcia, J; de Pipaon, MRP; Alastruey-Izquierdo, A; Garcia-Vidal, C.

    Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    JOURNAL OF INFECTION. 2023; 87(1): 46-53 Nº de citas: 56 [doi:10.1016/j.jinf.2023.05.005]

  • Pérez-Nadales E; Fernández-Ruiz M; Natera AM; Gutiérrez-Gutiérrez B; Mularoni A; Russelli G; Pierrotti LC; Pinheiro Freire M; Falcone M; Tiseo G; Tumbarello M; Raffaelli F; Abdala E; Bodro M; Gervasi E; Fariñas MC; Seminari EM; Castón JJ; Marín-Sanz JA; Gálvez-Soto V; Rana MM; Loeches B; Martín-Dávila P; Pascual Á; Rodríguez-Baño J; Aguado JM; Martínez-Martínez L; Torre-Cisneros J.

    Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.

    AMERICAN JOURNAL OF TRANSPLANTATION. 2023; 23(7): 1022-1034 Nº de citas: 26 [doi:10.1016/j.ajt.2023.03.011]

  • Mesquida, A; Machado, M; Davila-Cherres, L; Vicente, T; Sanchez-Carrillo, C; Alcala, L; Reigadas, E; Munoz, P; Guinea, J; Escribano, P.

    The Gastrointestinal Tract Is Pinpointed as a Reservoir of Candida albicans, Candida parapsilosis, and Candida tropicalis Genotypes Found in Blood and Intra-Abdominal Samples

    Journal of Fungi. 2023; 9(7): Nº de citas: 9 [doi:10.3390/jof9070732]

  • Gonzalez, CGR; de Vega, EC; Martinez, SD; Minero, MV; Urbon, JMG; Manzorro, AG; Martinez, EFD; Sacristan, SC; Santiago, EB; Alonso, AH; de Paredes, PMG; Saez, MS.

    A critical view on the current use of daptomycin in Spain: The daptomise study

    Journal of Infection and Public Health. 2023; 16(7): 1115-1122 Nº de citas: 1 [doi:10.1016/j.jiph.2023.05.008]

  • Cobo-Vazquez, E; Aguilera-Alonso, D; Carbsyo, T; Figueroa-Ospina, LM; Sanz-Santaeufemia, F; Baquero-Artigao, F; Vazquez-Ordonez, C; Carrasco-Colom, J; Blazquez-Gamero, D; Jimenez-Montero, B; Grasa-Lozano, C; Cilleruelo, MJ; Alvarez, A; Comin-Cabrera, C; Penin, M; Cercenado, E; Del Valle, R; Roa, MA; Garcia-De Diego, I; Calvo, C; Saavedra-Lozano, J.

    Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain

    EUROPEAN JOURNAL OF PEDIATRICS. 2023; 182(7): 3057-3062 Nº de citas: 19 [doi:10.1007/s00431-023-04967-5]

  • Escrihuela-Vidal, F; Berbel, D; Fernandez-Hidalgo, N; Escola-Verge, L; Munoz, P; Olmedo, M; Goenaga, MA; Goikoetxea, J; Farinas, MC; De Alarcon, A; Miro, JM; Ojeda, G; Plata, A; Cuervo, G; Carratala, J; GAMES Investigators.

    Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci

    CLINICAL INFECTIOUS DISEASES. 2023; : Nº de citas: 7 [doi:10.1093/cid/ciad375]